CA1040081A - Method for analysis of endotoxin-precipitated limulus lysate - Google Patents

Method for analysis of endotoxin-precipitated limulus lysate

Info

Publication number
CA1040081A
CA1040081A CA224,426A CA224426A CA1040081A CA 1040081 A CA1040081 A CA 1040081A CA 224426 A CA224426 A CA 224426A CA 1040081 A CA1040081 A CA 1040081A
Authority
CA
Canada
Prior art keywords
protein
precipitated
solution
endotoxin
pyrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA224,426A
Other languages
French (fr)
Inventor
Rajiva Nandan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Application granted granted Critical
Publication of CA1040081A publication Critical patent/CA1040081A/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/579Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

IMPROVED METHOD FOR ANALYSIS OF ENDOTOXIN-PRECIPITATED LIMULUS LYSATE

Inventor: Rajiva Nandan ABSTRACT OF THE DISCLOSURE

A method for quantitatively determining the concentra-tion of bacterial endotoxin in various materials has been developed. This method comprises adding to the test material a purified, standardized solution of Limulus amoebocyte lysate, and thereafter measuring photometrically the amount of pre-cipitated protein. The degree of protein precipitation is directly dependent upon the concentration of endotoxin and concentration of precipitable protein in the amoebocyte lysate.

Description

-BACKGROUND OF THE INVENTION

As has frequently been discussed in the published literature (For example, Thrombos. Diath. Hemorrage, Vol. 23, Pages 170-181 (1970), the amoebocyte blood cells of members of the genus Limulus, and particularly Limulus polyphemus, the horseshoe crab, form clots when placed in contact with pyrogens such as bacterial endotoxin. These amoebocyte cells provide an effective blood clotting mechanism to an injured horseshoe crab, thereby preventing further proliferation and migration of bacteria into other parts of the body.
At the present time invivo pyrogen testing of parenteral solutions is performed in rabbits. Such a test program is very expensive and difficult to operate.
A considerable amount of research has been invested in the use o~ Limulus amoebocytes, after lysing them in water or the like to rupture the cells, as a substitute testing means ~or pyrogens in sterile products. One typical summary of such recent work with Limulus is found in the Bulletin of the Parenteral Drug ssociation, Vol. 27, No. 3, Pages 139-148 ~May-June, 1973).
Typically, the Limulus amoebocyte cells are lysed by placing them in distilled water, or by any other convenient means for rupturing the blood cells. Following this, the re-sulting solution is filtered or centrifuged, to remove solids such as cell wall fragments and the like, to yield a protein solution, commonly referred to as Limulus lysate.
This protein solution (Limulus Lysate) is conventionally used to detect bacterial endotoxin by bringing it into contact
- 2 - ~ `

with the material to be tested, and observing whether or not a clot of protein is formed which has certain minimum standards of stability. One typical testing standard for stability of the clot is to invert the test tube in which the clot is formed by 180. If the clot remains intact, a positive endotoxin reaction is recorded. If the clot breaks up, or if no intact clot is ever formed, a negative endotoxin reaction is recorded.
A disadvantage of the clot technique for determining the presence of pyrogens is that the results can vary, depend-ing on how the observer inverts the test tube, and also de-pending on his subjective interpretation of what constitutes a "clot."
Thus, while the above-described clot-formation technique of analysis for endotoxin is satisfactory for some uses, there are many important and critical endotoxin determinations which must be made, for which a simple clotting type of endotoxin determination has inadequate accuracy and sensitivity to give a sufficiently precise analysis of the presence of endotoxin.
One very important use in this category involves the pyrogen testing of parenteral solutions, as a substitute for the present, expensive and cumbersome live rabbit testing pro-gram, which is commonly used by commercial manufacturers of parenteral solutions.
Accordingly, there is a need for a more accurate, quantitative, and sensitive determination in-vitro for the presence of pyrogens such as bacterial endotoxin.
The invention of this application provides a quantitative, improved technique for the determination of pyrogens such as bacterial endotoxin through the use of Limulus lysate materials.

~*.~ use of the method of this invention, a major increase in the sensitivity of detection of endotoxin is achieved, and the con-centration of endotoxin present can be quantitatively determined.

DESCRIPTION OF T~E INVENTION
In one particular aspect the present in.vention provides the method of calibrating a purified solution of pyrogen-precipit-able portions of the lysate of Limulus blood cells for its quan-titative sensitivity to the presence of pyrogens such as bacterial endotoxin, which comprises: (a) preparing a series of serially diluted dispersions of a pyrogen which precipitates Limulus pro~
teins, a plurality of said serially diluted dispersions having pyrogen concentrations of no more than 0.39 nanogram per ml.; (b) adding to each of sald series of dispersions an equivalent con-centration of said purified, pyrogen precipitable protein of Limulus lysate solution; ancl (c) thereafter measuring, in a quan-titative photometric manner, the amount of protein precipitated, whereby an abrupt increase in the amount of precipitated protein in one member of said serially diluted series of dispersions of no more than 0.3~ nanogram per ml. concentration, when compared with the next more diluted member o~ said serially diluted series, indicates a positive pyrogen sensing reaction; and (d) analysing the material having an unknown.pyrogen content by adding to said material said equivalent concentration of a previously unused portion of said purified Limulus protein solution under conditions essentially equivalent to step (b) above ! and thereafter measuring, in quantitative, photometric manner, the amount of protein pre-cipitated in said material from said pyrogen precipitable por-tions, whereby the precipitation of a concentration of protein : which is at least equal to the concentration of protein precipi-tated in a said member of the serially d~luted series of dis-persions in which said abrupt increase in precipitated protein was noted constitutes an indication of a positive reac-tion to .~ jc/:'';' ' /rogen in said material of unknown pyrogen content.
A purified solution of precipitable protein of Limulus lysate is typically used, in which excess amounts of extraneous protein which do not precipitate in the presence of pyrogens has been removed. These latter pro-teins tend to reduce the sensitivi-ty of the analytical results obtained in accordance with this invention. Thus, it is desired to remove by filtration or cen-trifugation, or the like, the cell wall fragments and other solid portions of Limulus lysate, as well as at least some water-soluble, nonprecipitable protein fractions. A preferred technique for purification of the Limulus lysate protein is shown in the example below, but other purification techniques may be used as desired.
Simpler and less effective purification techniques may be used in those cases where results of the high accuracy of Example 1 below are not required.
The serially diluted dispersions of pyrogen used in Step ta) of the calibration step described above may be prepared from commercially available standard endotoxin solu-tion. Typic-ally, a series of successively diluted solutions are prepared having 20 difEerent bacte.rial endotoxin concentrations, in which the first solution of highest concentration contains .~ ~ jc/~
~ ..

100 nanograms of endotoxin per ml., in which each successive test solution contains one-half of the concentration of the previous test solution, so that -the twentieth and last solu-tion contains 0.00019 nanogram of endotoxin per ml.
Following this, a measured quantity, preferably the same quantity per vial, of purified, precipitable protein of Limulus lysate solution is added to each of the serially di-luted pyrogen dispersions, and the dispersions are generally allowed to stand for a period of time, such as 60 minutes, typically at a warm temperature such as 37 C. However, the tests can be effectively practiced with other incubation times and at a relatively wide range of different temperatures, although it is preferred for all of the samples or vials in a test to be processed in a uniform manner.
During incubation, a clot of precipitated protein may appear in vials containing endotoxin of higher concentration, which has been used as a prior indication of positive reaction.
However, the method of this invention is considerably more sensitive than a clot indication, and can detect the presence of endotoxin at a much lower concentration.
Following the incubation step, the amount of protein precipitated is measured in a quantitative, photometric manner.
This is generally accomplished by centrifuging or filtering i the precipitated protein, to separate it from the supernatant.
The purpose of this is to remove as much unprecipitated pro-tein as possible from the solution, to facilitate the quanti-tative measurement of the amount of precipitated protein re-maining.
Following this, the protein can be redispersed in any desired manner, and quantitatively, photometrically measured ., using, for example, well-known techniques of absorbence, Elourescence, or light scattering.
It is generally preferable to use absorbence princi-ples, measuring the protein content in an electromagnetic wavelength range of ~50 to 1000 millimicrons, and particularly using the analytical technique described by Oliver H. Lowry, et al. in the article in Journal of Biological Chemistry, Vol. 93, pp, 265 to 275 (1951).
Preferably, each aliquot of solution tested contains sufficient precipitatable protein to provide an absorbence of less than 0.2 in the essential absence of endotoxin, and an absorbence in excess of 1 upon complete protein precipitation, at the wavelength observed.
When the precipitated protein samples from the serially diluted dispersions of pyrogen are analyzed photometrically, using an absorbence principle, one can obtain a specific absorbence reading for each sample which correlates with a specific concentration of endotoxin of each known sample.
Thereafter, utilizing the same calibrated Limulus lysate material and the same reaction conditions, one can analyze materials of unknown pyrogen content by adding to the material a measured quantity of a previously unused portion of the same purified Limulus protein solution, and thereafter measuring in the same photometric manner the amount of protein precipi-tated. Accordingly, an optical density reading, which is similar to an optical density reading of a specific tube of known endotoxin concentration also measured, is an indication that a similar concentration of pyrogen is present in the unknown material.

Alternatively, the decrease in photoabsorbence or the like in the supernatant solution can be measured, after re-moval of precipitated proteins, from which the amount of protein precipitated can be determined.
As a modification of the invention of this application, one can determine the concentration and effectiveness of a given Limulus protein by preparing a series of serially diluted dispersions of a Limulus pro-tein, and adding a measured excess quantity of bacterial endotoxin of known concentration to the solution, sufficient to precipi-tate all precipitable lysate protein.
One thereafter measures, in quantitative, photometric manner, the amount of protein precipitated, which in this case is the amount of precipitable Limulus protein present.
Accordingly, one can determine the strength of a given sample of Limulus lysate by quantitative measurement of its precipitation in the presence of a known excess of endotoxin.
The following example is for descriptive purposes only, and is not to be considered as limiting the invention of this application, which is as defined in the claims below.

Example 1.
Atlantic Ocean horseshoe crabs (Limulus PolyPhemus) were collected and placed in a rack to restrain them in a position with their ventral sides facing upwardly. The joint between the first two segments of the crabs(the prosthoma and the opisthoma) was prepared by swabbing with alcohol. The joint was then penetrated with a blood collection needle mounted on the end of a conventional blood bag manufactured by the Fenwal Division of Travenol Laboratories, Inc., Morton Grove, Illinois, but modified so that the blood collection tube was only 5 inches in length. The bag contained 300 ml. of 3 percent (weight/volume in grams per 1.) sodium chloride solution, containing 2.~7 grams of dissolved ethylene-diaminetetracetate, (EDTA).
The horseshoe crabs were bled one by one as necessary until 300 ml. of blood has passed into the blood bag, which had a 600 ml. capacity. The five-inch blood donor tubing was sealed near its entrance to the bag with a dielectric heat sealer (HEMATRON ~ heat sealing unit sold by the Fenwal Division of Travenol Laboratories, Inc.). The blood collection tube was then cut off near the heat-sealed section, to remove the needle.
Two bags, prepared as shown, were selected and balanced as necessary with weights, and then spun in a Sorvall RC 3 centriuae for seven minutes at a 1,000 Gravity force (about 1,300 rpm.), to cause the amoebocyte cells rom the Limulus blood to settle. In cases where the blood appears to be sedi-menting well, it is sometimes sufficient to only apply a 600 Gravity force (about 1,500 rpm.) for seven minutes.
Following the cell centrifuging step, each blood bag was placed on a 10 inclined plane with the sealed stub of the blood collection tubing pointed downwardly, and the collection tubing was once again opened by cutting. The supernatant was decanted carefully, to leave the settled cells remaining in the bag. Following the decanting step, the collection tubing was once again heat sealed in the manner previously described.
Following this, one of the two sterile access ports (m~dication ports) of the blood bags was entered wit.h an in-jection needle, and six parts by weight of distilled, non-pyro-genic water were added for each one part by weight of cellspresent in the bag, for lysis of the cells. The weight of the cells can be determined conveniently by subtracting the standard dry weight of the blood bag from the actual weight of the specific bag and the cells contained therein.
The distilled water was agitated in the blood bag, and then allowed to stand for 24 hours at 4C. Following this, the bag was centrifuged at a 1,000 Gravity force for seven minutes.
Following this, the liquid contents of each bag were passed through a 170 micron filter (a sterile Fenwal in line filter set, available from the Fenwal Division of Baxter Laboratories, Inc., Morton Grove, Illinois), to separate them from the settled solids, and placed in a freezing environment until solidly frozen.
The frozen Limulus lysate solution was then carefully thawed, while assuring that the solution remained cold (i.e.
below about 20C.). After thawing, the Limulus lysate solu-tion was ptefiltered into a pooling bdttle through an addi-tional Fenwal 170 micron filter.
The filter residue remaining behind in the filter is unwanted material which has precipitated during the freezing step. The filtrate then is typically filtered once again through another filter (a Millipore type AP25 prefilter having a nominal pore size of 1.5 microns), followed by filtration with a Millipore membrane filter, stated to have an absolute pore size of 1.2 microns, and a nominal pore size of less than that. ~ nominal pore size is defined as that pore diameter which removes at least 98 per cent of all particles of the size stated.

Prior to use, all filters are rinsed with 1 liter of sterile, non-pyrogenic water. The last filtration steps pro-ceed by pressurizing the lysate solution upstream o the filter with approximately 2 lbs. of nitrogen gas pressure.
Alternatively, vacuum in the collection vessel can be used to facilitate filtration.
After the last filtering step, the solution is sub-divided into 2.0 ml. aliquots, which are placed in 6 ml.
vials or -test tubes, which have been thoroughly washed with sterile pyrogen-free water, and depyrogenated at 245C for 4 hours. The test tubes are then conventionally sealed and shelf-frozen in a lyophilization machine (Virtis Lyophilizer), and allowed to freeze-dry until a dry powder remains.

Reconstitution and Use of Limulus Lysate `~ number of the test tubes prepared in the manner de-scribed above, were each reconstituted by the addition of 5 ml.
of an equal volume mixture of 1 weight per cent magnesium chloride solution and 0.1 weight per cent sodium thioglycollate solution.
To calibrate the Limulus lysate, 0.1 ml. of non-pyrogenic water was placed into each of a series of empty test tubes,ex-cept the first tube. To the first tube was added 0.2 ml. of E. coli standard endotoxin solution (commercially available from Difco Laboratories, Detroit, Michigan). The concentration of the E. coli endotoxin used ranged from 100 nanograms of endo-toxin per ml. Following this, 0.1 ml. of solution from the first tube was added to the second tube; and 0.1 ml. of solution ....

from the second tube was added i:o the third tube; with this process being continued to form a series of successive test solutions each containing one-half of the concentration of the previous test solution, so that the twentieth and last Co ~ ~o~ ~ e~
test solution ~ah~a7he~ 0.00019 nanogram of endotoxin per ml..
The sixth through the sixteenth numbers of this series were selected for use.
To s~veral of the resulting tubes of solution there was added 0.1 ml. of the filtered lysate solution prepared above.
The series of tubes were then incubated at 37 C. for 60 minutes. Each tube was then inverted, and the presence or absence of an intact protein clot was noted.
Thereafter, all clots were broken up, and the tubes were centrifuged at 4,000 rpm. for 15 minutes. Following this, the supernatant liquid was removed from each tube, to remove dissolved protein, while any settled precipitate was allowed to remain in the tube.
To each tube was then added 0.2 ml. of 0.75 N sodium hydroxide solution to dissolve the protein precipitate.
Following this, the protein content of each vial was quantitatively analyzed in a manner similar to the procedure of Oliver H. Lowry, et al. as described in the article in Journal of Biolo~ical Chemistry, Vol. 193, pages 265-275 (1951).

. :~

-1~34~

The following reagents were used in the test described below:

Reagent A 20 grams/liter sodium carbonate in 0.1 N sodium hydroxide solution Reagent B 5 grams/liter CuSO4.5H O in 10 grams/
liter potassium tartra~e solution Reagent C alkaline copper solution made by mixing 49 ml. of Reagent A with 1 ml. of Reagent s. This material should be preapred fresh each day.

Reagent D diluted Folin reagent made by dilu-ting of Folin-Ciocalteu phenol reagent (available from Fisher Scientific Co. or Harleco Company) diluted to 1 N with distilled water.
To each sample of protein solution in the vials prepared previously, one ml. o Reagent C was added. The mixture was thoroughly mixed and allo~,led to stand for about ten minutes at room temperature. Following this, 0.1 ml. of Reagent D was added rapidly and mixed within less than ten seconds, after which it was allowed to stand for at least thirty minutes at room temperature.
A Gilford 300 N spectrometer was set to measure absor-bence on an optical density scale at a wavelength of 500 m~.
The spectrophotometer was equipped with a micro (0.5 ml.~ flow-through cuvette to accommodate the small volume of the samples.
The spectrometometer setting may typically range between 450 and 1000 m~ but preferably is in the range of 500 and 750 m~.
The spectrophotometer was adjusted to a zero absorbence reading with a blank standard comprising a solution of 0.75 N
NaOH containing similar concentrations of solutions C and D.
Under this technique, the concentration of lysate added is enough to give an absorbence reading in excess of 1 upon com-plete precipitation of the protein, and an absorbence reading o~ ~

of less than 0.2 in the essential absence of precipitation (and endotoxin).
Following this, the absorbence of samples previously prepared was measured in terms of optical density and recorded.
The results are as indicated below:

Concentration oE Absorbence of Calculated amount Endotoxin added precipitated of precipitated to Lysate solution protein protein (micro-(nanograms per ml.) grams per 0.1 ml.
Lysate) solution
3.12 (Solution No. 6) 1.031 425 1.56 (Solution No. 7) 1.110 475 0.78 (Solution No. 8) 1.386 (Absorbence is too high to accurately calculate protein).
0.39 (Solution No. 9) 0.941 370 0.195 (Solution No. 10) 0.913 350 0.097 (Solution No. 11) 0.958* 375 0.048 (Solution No. 12) 0.814 287 0.024 (Solution No. 13) 0.682 210 o.Ol2 (Solution No. 14) 0.535 132 0.006 (Solution No. 15) 0.350 77.5 ... .
0.003 (Solution No. 16) 0.378 82.5 Control lysate solution 0.136 37.5 with no added endotoxin *This was the lowest concentration of endotoxin which was capable of forming a conventional protein clot positive re-action.

, From the above Table 1 it can be seen that there is a sharp rise in the amount of protein precipitated in the range of solutions beginning with solution No. 14 and ending with solution No. 11. When one compares, in this series of solutions, the amount of protein precipitated by each Member of the series with the next more dilute member of the series, there is noted a clear increase in the amount of protein pre-cipitated. This is a clear indication that the increasing levels of endotoxin are causing increasing amounts of protein to precipitate, and constitutes typical behavior of purified Limulus protein in the presence of endotoxin.
Accordingly, it can be seen that the test of this Example is sensitive to the presence of endotoxin at concen-tration levels as low as 0.0012 nanogram per ml. of test solu-tion, since the protein precipitated in solution No. 14 is substantially greater in amount than the protein precipitated in solution No. 15. The endotoxin sensing reaction is con-firmed by the further increase in precipitated protein by solutions 13, 12 and 11. One can also note that a suspected endotoxin reaction exists at concentrations as low as 0.0003 nanogram per ml. (solution No. 16), since the precipitated protein level of even that extremely diluted sample is subs-tantially above the control lysate solution having no added endotoxin.
Accordingly, when an unknown sample is tested under conditions identical to that described above, using an unused portion of the same lot of purified lysate solution, one can quantitatively analyze the concentration of pyrogen present, particularly endotoxin, by correlation with the absorbence readlng for the unknown sample. For example, an unknown sample treated in accordance with the above Example which exhibits an absorbence reading of about 0.535 can be known to have an endotoxin concentration of approximately that of solution No. 14 in Table 1 above. Higher readings correspond to the higher endotoxin levels of the more concentrated solutions as shown, although it will be noted that the readings appear to develop some quantitative error at the more concentrated levels (solution No. 11 and higher). However, these readings still retain rough accuracy, and also are usable for qualita-tive indications of the presence of endotoxin.
The above data is to be compared with the conventional clot formation technique of analysis, in which the presence of endotoxin is indicated by the formation of a clot in the reaction tube which does not break up when the test tube is carefully inverted by 180. By this analysis technique, the most dilute solution in the above experiment which gave a positive endotoxin reaction was solution No. 11, having a concentration oE 0.097 nanogram per ml. Accordingly, the above example provides an endotoxin determination which is eight times more sensitive than the conventional clot endotoxin determination.

Claims (7)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. The method of calibrating a purified solution of pyrogen-precipitable portions of the lysate of Limulus blood cells for its quantitative sensitivity to the presence of pyrogens such as bacterial endotoxin, which comprises:
(a) preparing a series of serially diluted dispersions of a pyrogen which precipitates Limulus proteins, a plurality of said serially diluted dispersions having pyrogen concentrations of no more than 0.39 nanogram per ml.;
(b) adding to each of said series of dispersions an equi-valent concentration of said purified, pyrogen precipitable pro-tein of Limulus lysate solution; and (c) thereafter measuring, in a quantitative photometric manner, the amount of protein precipitated, whereby an abrupt increase in the amount of precipitated protein in one member of said serially diluted series of dispersions of no more than 0.39 nanogram per ml. concentration, when compared with the next more diluted member of said serially diluted series, indicates a positive pyrogen sensing reaction; and (d) analyzing the material having an unknown pyrogen content by adding to said material said equivalent concentration of a previously unused portion of said purified Limulus protein solution under conditions essentially equivalent to step (b) above, and thereafter measuring, in quantitative, photometric manner, the amount of protein precipitated in said material from said pyrogen precipitable portions, whereby the precipitation of a concentration of protein which is at least equal to the concen-tration of protein precipitated in a said member of the serially diluted series of dispersions in which said abrupt increase in precipitated protein was noted constitutes an indication of a positive reaction to pyrogen in said material of unknown pyrogen content.
2. The method of claim 1 in which said precipitated protein is measured by removing said precipitated protein from its supernatant solution from which it was precipitated, and thereafter quantitatively determining the amount of precipitated protein present by measuring the relative photoabsorbence, com-pared with a control protein, of a solution of said precipitated protein with Folin reagent at a wavelength between 450 and 1,000 millimicrons.
3. The method of claim 2 in which said wavelength is 500 to 750 millimicrons.
4. The method of claim 3 in which the amount of protein in each predetermined aliquot of purified solution which is added to each of said series of dispersions is sufficient to provide a photoabsorbence in the wavelength observed of less than 0.2 in the essential absence of endotoxin, and a photoabsorbence in the wave-length observed in excess of 1 in the presence of sufficient endo-toxin to precipitate essentially all of said precipitable protein.
5. The method of claim 1 which includes the step of incubating the reaction mixture to allow the reaction to go to essential completion between said steps (b) and (c).
6. The method of claim 5 in which each member of said serially diluted series of dispersions is one-half the concen-tration of the next more concentrated member of said serially diluted series.
7. The method claim 5 in which a plurality of said serially-diluted dispersions have endotoxin concentrations of less than 0.097 nanogram per ml.
CA224,426A 1974-05-01 1975-04-11 Method for analysis of endotoxin-precipitated limulus lysate Expired CA1040081A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46599074A 1974-05-01 1974-05-01

Publications (1)

Publication Number Publication Date
CA1040081A true CA1040081A (en) 1978-10-10

Family

ID=23849996

Family Applications (1)

Application Number Title Priority Date Filing Date
CA224,426A Expired CA1040081A (en) 1974-05-01 1975-04-11 Method for analysis of endotoxin-precipitated limulus lysate

Country Status (6)

Country Link
JP (1) JPS50147989A (en)
AU (1) AU497873B2 (en)
CA (1) CA1040081A (en)
DE (1) DE2517860C3 (en)
FR (1) FR2280083A1 (en)
GB (1) GB1499846A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944391A (en) * 1974-12-27 1976-03-16 Preventive Systems, Inc. In vitro process for detecting endotoxin in a biological fluid
US4221865A (en) 1978-10-06 1980-09-09 Baxter Travenol Laboratories, Inc. Method for determining endotoxin concentration
US4221866A (en) 1978-10-06 1980-09-09 Baxter Travenol Laboratories, Inc. Method for determining endotoxin concentration
US4376819A (en) 1979-09-14 1983-03-15 Baxter Travenol Laboratories, Inc. Biological extracts and method for making same
DE68916714T2 (en) * 1988-07-05 1995-01-12 Wako Pure Chem Ind Ltd Procedure for the determination of endotoxins.

Also Published As

Publication number Publication date
FR2280083B1 (en) 1982-02-05
DE2517860C3 (en) 1980-01-03
GB1499846A (en) 1978-02-01
AU8069175A (en) 1976-11-04
AU497873B2 (en) 1979-01-18
FR2280083A1 (en) 1976-02-20
DE2517860B2 (en) 1979-04-19
DE2517860A1 (en) 1975-11-13
JPS50147989A (en) 1975-11-27

Similar Documents

Publication Publication Date Title
US4108972A (en) Immunological reagent employing radioactive and other tracers
US3853987A (en) Immunological reagent and radioimmuno assay
Boyden et al. Precipitin testing with special reference to the photoelectric measurement of turbidity
EP0064274B1 (en) Method for assaying antigen-antibody reactions and reagent therefor
US3826613A (en) Detection and titration of viruses and antibodies using latex
CA1167751A (en) Antibody detection process
US5919419A (en) Analyzer cuvette, method and diagnostic test kit for determination of analytes in whole blood samples
EP0082862B1 (en) A method of detecting or determining histamine in histamine containing materials, particularly body fluids and an analytical means for use in such method
Ault The clinical utility of flow cytometry in the study of platelets
CA1040081A (en) Method for analysis of endotoxin-precipitated limulus lysate
WO1989005092A1 (en) Conservative whole blood sample preparation technique
CA1144461A (en) Chromogenic detection of endotoxin in human serum and plasma
Ahluwalia et al. Spot ferritin assay for serum samples dried on filter paper
US4429040A (en) Method and reagent for the detection of fibrin monomer
Tasker et al. Evaluation of methods of platelet counting in the cat
NO159964B (en) IMMUNOCHEMICAL REAGENTS.
US3733398A (en) Determining and reversing anticomplementary activity in complement fixation test for australia antigen
US3476514A (en) Cancer cytoscreening
JP2002533712A (en) Free cell sample analysis method
Yeromenko et al. The relevance of the development and implementation of quality system in clinical diagnostic laboratories
Handriani et al. Optimization of Polyethylene Glycol Concentration as an Agglutination Potentiator for Examination of Blood Types of Dry Blood Sample
Branum et al. Effect of two anticoagulants on leukocyte yield and function, and on lysosomal enzyme activity.
CA1060323A (en) Limulus lysate turbidity test for pyrogens
JPS6262291B2 (en)
JPH0456258B2 (en)